Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Shytle

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|May 17, 2001
Mecamylamine: new therapeutic uses and toxicity/risk profileJ M Young, R D Shytle, P R Sanberg, et al.
Journal of Human Hypertension|June 25, 2002
Mecamylamine (Inversine): an old antihypertensive with new research directionsR D Shytle, E Penny, A A Silver, et al.
Australian and New Zealand Journal of Medicine|August 1, 1996
Smoking cessation programmes are neglecting the needs of persons with neuropsychiatric disordersS Polgar, M McGartland, C V Borlongan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 24, 2001
Corticosterone-attenuating and anxiolytic properties of mecamylamine in the ratM B Newman, S J Nazian, P R Sanberg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 15, 2001
Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorderA A Silver, R D Shytle, K H Sheehan, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1995
Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral arteryC V Borlongan, R Martinez, R D Shytle, et al.
Molecular Psychiatry|July 26, 2002
Nicotinic acetylcholine receptors as targets for antidepressantsR D Shytle, A A Silver, R J Lukas, et al.
The Journal of Clinical Psychiatry|October 30, 2001
Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled studyA A Silver, R D Shytle, M K Philipp, et al.
Experimental Neurology|December 1, 1995
(-)-nicotine protects against systemic kainic acid-induced excitotoxic effectsC V Borlongan, R D Shytle, S D Ross, et al.
The International Journal of Neuroscience|November 9, 2001
Mecamylamine effects on haloperidol-induced catalepsy and defecationP R Sanberg, M B Newman, J J Manresa, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|May 17, 2001
Mecamylamine: new therapeutic uses and toxicity/risk profileJ M Young, R D Shytle, P R Sanberg, et al.
Journal of Human Hypertension|June 25, 2002
Mecamylamine (Inversine): an old antihypertensive with new research directionsR D Shytle, E Penny, A A Silver, et al.
Australian and New Zealand Journal of Medicine|August 1, 1996
Smoking cessation programmes are neglecting the needs of persons with neuropsychiatric disordersS Polgar, M McGartland, C V Borlongan, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 24, 2001
Corticosterone-attenuating and anxiolytic properties of mecamylamine in the ratM B Newman, S J Nazian, P R Sanberg, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 15, 2001
Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorderA A Silver, R D Shytle, K H Sheehan, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1995
Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral arteryC V Borlongan, R Martinez, R D Shytle, et al.
Molecular Psychiatry|July 26, 2002
Nicotinic acetylcholine receptors as targets for antidepressantsR D Shytle, A A Silver, R J Lukas, et al.
The Journal of Clinical Psychiatry|October 30, 2001
Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled studyA A Silver, R D Shytle, M K Philipp, et al.
Experimental Neurology|December 1, 1995
(-)-nicotine protects against systemic kainic acid-induced excitotoxic effectsC V Borlongan, R D Shytle, S D Ross, et al.
The International Journal of Neuroscience|November 9, 2001
Mecamylamine effects on haloperidol-induced catalepsy and defecationP R Sanberg, M B Newman, J J Manresa, et al.
Pageof 3